Literature DB >> 24989704

Chain-terminating and clickable NAD⁺ analogues for labeling the target proteins of ADP-ribosyltransferases.

Yan Wang1, Daniel Rösner, Magdalena Grzywa, Andreas Marx.   

Abstract

ADP-ribosyltransferases (ARTs) use NAD(+) as a substrate and play important roles in numerous biological processes, such as the DNA damage response and cell cycle regulation, by transferring multiple ADP-ribose units onto target proteins to form poly(ADP-ribose) (PAR) chains of variable sizes. Efforts to identify direct targets of PARylation, as well as the specific ADP-ribose acceptor sites, must all tackle the complexity of PAR. Herein, we report new NAD(+) analogues that are efficiently processed by wild-type ARTs and lead to chain termination owing to a lack of the required hydroxy group, thereby significantly reducing the complexity of the protein modification. Due to the presence of an alkyne group, these NAD(+) analogues allow subsequent manipulations by click chemistry for labeling with dyes or affinity markers. This study provides insight into the substrate scope of ARTs and might pave the way for the further developments of chemical tools for investigating PAR metabolism.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ADP-ribosylation; ARTD1; NAD+; poly(ADP-ribosy)lation; posttranslational modifications

Mesh:

Substances:

Year:  2014        PMID: 24989704     DOI: 10.1002/anie.201404431

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  13 in total

1.  Emissive Synthetic Cofactors: Enzymatic Interconversions of tz A Analogues of ATP, NAD+ , NADH, NADP+ , and NADPH.

Authors:  François Hallé; Andrea Fin; Alexander R Rovira; Yitzhak Tor
Journal:  Angew Chem Int Ed Engl       Date:  2017-12-21       Impact factor: 15.336

2.  Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue.

Authors:  Alexander R Rovira; Andrea Fin; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2017-10-27       Impact factor: 15.419

3.  Chemoenzymatic Preparation of 4'-Thioribose NAD.

Authors:  Xiao-Nan Zhang; Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2019-04-05

4.  Investigation of the action of poly(ADP-ribose)-synthesising enzymes on NAD+ analogues.

Authors:  Sarah Wallrodt; Edward L Simpson; Andreas Marx
Journal:  Beilstein J Org Chem       Date:  2017-03-10       Impact factor: 2.883

Review 5.  Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.

Authors:  Elizaveta E Alemasova; Olga I Lavrik
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

6.  An Integrated Chemical Proteomics Approach for Quantitative Profiling of Intracellular ADP-Ribosylation.

Authors:  Karunakaran Kalesh; Saulius Lukauskas; Aaron J Borg; Ambrosius P Snijders; Vinay Ayyappan; Anthony K L Leung; Dorian O Haskard; Peter A DiMaggio
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

7.  A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation.

Authors:  Xiao-Nan Zhang; Qinqin Cheng; Jingwen Chen; Albert T Lam; Yanran Lu; Zhefu Dai; Hua Pei; Nikolai M Evdokimov; Stan G Louie; Yong Zhang
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

Review 8.  Chemical Tools to Study Protein ADP-Ribosylation.

Authors:  Gerbrand J van der Heden van Noort
Journal:  ACS Omega       Date:  2020-01-22

Review 9.  Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report.

Authors:  Hajar Aryan; Ehsan Razmara; Dariush Farhud; Marjan Zarif-Yeganeh; Shaghayegh Zokaei; Seyed Abbas Hassani; Mahmoud Reza Ashrafi; Masoud Garshasbi; Ali Reza Tavasoli
Journal:  BMC Neurol       Date:  2020-08-03       Impact factor: 2.474

Review 10.  NAD Analogs in Aid of Chemical Biology and Medicinal Chemistry.

Authors:  Anais Depaix; Joanna Kowalska
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.